Severe colitis while responding to ipilimumab in metastatic melanoma

Acta Oncol. 2012 Jul;51(6):805-7. doi: 10.3109/0284186X.2012.682630. Epub 2012 May 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Colitis / chemically induced*
  • Female
  • Humans
  • Ipilimumab
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Middle Aged
  • Prognosis

Substances

  • Antibodies, Monoclonal
  • Ipilimumab